Study of an experimental anemia drug for chronic kidney disease patients not on dialysis
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage 3, 4, or 5 chronic kidney disease (not on dialysis).
- Your recent red blood cell counts (hemoglobin) are low but above certain minimums depending on whether you've had prior anemia treatment.
- You have not had a stroke, heart attack, or blood clot in the last 6 months.
- Your liver and heart function are reasonably healthy, and your blood pressure is under control.
- You have not taken other experimental anemia drugs or had certain stomach surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This study tests different starting doses of a pill called enarodustat to see which works best for anemia in people with chronic kidney disease who are not on dialysis. It aims to help raise red blood cell counts and reduce the need for injections.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
This study tests a new drug called Efepoetin Alfa to treat anemia in people with chronic kidney disease who are on dialysis. The goal is to see if it can safely raise red blood cell levels and reduce the need for other anemia treatments.
This study tests an oral medication (AND017) to see if it can safely help raise hemoglobin levels in people with anemia caused by chemotherapy. If you have cancer (not leukemia) and are currently on chemo, this trial might help manage your anemia and improve your energy.
This trial tests a drug called luspatercept to see if it can raise hemoglobin levels in people with anemia caused by chronic kidney disease. It's for those whose current treatments aren't working well or who cannot use them.
Hear when a new Anemia Due to Chronic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.